Results 131 to 140 of about 27,824 (249)

Comorbidities Are Associated With Unfavorable Outcome in Aquaporin‐4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: Exploratory Study From the CROCTINO Cohort

open access: yesEuropean Journal of Neurology, Volume 32, Issue 6, June 2025.
ABSTRACT Background Comorbidities occur in aquaporin‐4 antibody‐positive neuromyelitis optica spectrum disorder (AQP4‐NMOSD), myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD), and double seronegative NMOSD (DN‐NMOSD), potentially contributing to a less favorable disease course.
Sara Samadzadeh   +63 more
wiley   +1 more source

Cutaneous Side Effects of PD‐1 Inhibitors: A Single‐Center Retrospective Study

open access: yesInternational Journal of Dermatology, Volume 64, Issue 6, Page 1066-1078, June 2025.
ABSTRACT Background The introduction of immune checkpoint inhibitors (ICIs) opened a new era in cancer immunotherapy. In particular, PD‐1 inhibitors have shown remarkable efficacy in various cancers, most notably melanoma. However, the widespread use of immune checkpoint inhibitors comes with the challenge of immune‐related adverse events (irAEs), with
Melánia Pozsgai   +5 more
wiley   +1 more source

Role of TGFβ in Development of Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice [PDF]

open access: bronze, 2001
Helen Braley‐Mullen   +3 more
openalex   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Type 2 Inflammation and Its Role in Dermatologic Diseases

open access: yesInternational Journal of Dermatology, Volume 64, Issue 6, Page 978-991, June 2025.
ABSTRACT Atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria are immune‐mediated, inflammatory skin conditions characterized by intense itch and disease‐specific skin lesions. Despite their different clinical presentations, the three diseases are unified by an aberrant type 2 immune response involving type 2 cytokines, immune cells,
Raj Chovatiya   +5 more
wiley   +1 more source

Monoclonal Antibodies to Thyrotropin Receptor With Thyroid‐Stimulating Activity Activate the NF‐κB Pathway to Induce Chemokine Expression

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 11, June 2025.
ABSTRACT The A subunit of thyrotropin receptor (TSHR) is thought to be the crucial gene mediating stimulatory autoantibodies in Graves' diease (GD), but it remains unclear what the molecular basis of this pathological antibody response is. Stimulatory TSHR autoantibodies may induce activation of multiple signalling pathways in GD, modulate chemokine ...
Yang Yang, Chen Hui
wiley   +1 more source

Effect of Dietary Iodine on Autoimmune Thyroiditis in the BB Wistar Rat

open access: bronze, 1989
Peter W.F. Fischer   +2 more
openalex   +1 more source

Induction of Experimental Autoimmune Thyroiditis in IL-12−/− Mice [PDF]

open access: bronze, 2001
Kemin Chen   +3 more
openalex   +1 more source

Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 6, Page 1163-1173, June 2025.
A post hoc analysis of Severity of Alopecia Tool (SALT) score trajectories in patients with alopecia areata who received ritlecitinib 50 mg once‐daily in ALLEGRO‐2b/3 and rolled over into the ongoing, open‐label, Phase 3 ALLEGRO‐LT study. Long‐term response patterns up to Month 24 and variables associated with treatment response are described. Abstract
B. King   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy